Drugmaker Merck is facing a class-action lawsuit in Canada over the osteoporosis med Fosamax.
The lawfirm Siskinds LLP has launched the suit against Merck Frosst Canada, claiming that Merck failed to adequately warn patients and doctors that Fosamax may increase users' risk of developing osteonecrosis of the jaw (ONJ), also known as "jaw death." ONJ causes pain, soft-tissue swelling and infection, loosening of teeth and exposed bone in the mouth.
Attorney Michael Peerless says that he hopes the lawsuit forces Merck to disclose what the company knows or has known about Fosamax's link to the jaw condition.
If you're interested in reading more about the link between Fosamax and ONJ, you can read about what some doctors have observed about the connection here. Also, this article summarizes the Mayo Clinic's opinion on the connection between ONJ and osteoporosis meds.
No comments:
Post a Comment